Rishi Anand, MD
Clinical Cardiac Electrophysiology · Fort Lauderdale, FLNPI 1487855649
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $16,365 of the $25,688 with a category attached, or 63.7%. Johnson & Johnson accounts for 66.4% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2019 at $12,852 and has fallen 80.0% since, to $2,565 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in FL, where the typical reported total is $25,729.
Across 349 payments — averaging $73.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$17K
- Boston Scientific$2K
- Biosense Webster, Inc.$2K
- Medtronic$2K
- Abbott$1K
- Cardiva Medical, Inc.$420
- plus $1K from 10 others
Across 43 payments — averaging $3278.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Portola Pharmaceuticals, LLC$90K
- AstraZeneca$51K
What the payments were for
- Consulting fees$3001%
- Speaking & faculty fees$16,36564%
- Travel & lodging$470%
- Food & beverage$8,97635%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 17 | $17,063 |
| Boston Scientific | 69 | $2,254 |
| Biosense Webster, Inc. | 121 | $1,718 |
| Medtronic(2 entities) | 55 | $1,674 |
| Abbott | 26 | $1,460 |
| Cardiva Medical, Inc. | 25 | $420 |
| Philips North America LLC | 2 | $160 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 13 | $156 |
| Cordis US CORP. | 2 | $147 |
| Novartis | 7 | $143 |
| AstraZeneca | 2 | $139 |
| Cvrx, Inc. | 4 | $110 |
| Cardiovascular Systems Inc. | 1 | $94 |
| Kestra Medical Technology Services, Inc. | 2 | $81 |
| Pfizer | 2 | $37 |
| Heartflow, Inc. | 1 | $32 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$16,915
- WATCHMAN Access System$385
- AVEIR$308
- Reveal LINQ$276
- LINQ II$267
- WATCHMAN FLX$217
- AURORA EV-ICD MRI SURESCAN$167
- COBALT DR MRI SURESCAN$166
- GALLANT$159
- (0843) Laser Parts Other$148
- Mitra Clip system$144
- ENSITE$140
- ANDEXXA$125
- Watchman$124
- Cobalt$119
- Farapulse$117
- Carto 3 System$115
- Assurity Pacemaker$111
- MYNX CONTROL$103
How this compares
$25,688 in reported general payments places this provider in the 45th percentile of 249 clinical cardiac electrophysiology providers in Florida.
See all clinical cardiac electrophysiology providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 158 | $153,015 |
| EntrestoSacubitril/Valsartan | 56 | $55,029 |
| XareltoRivaroxaban | 63 | $50,659 |
| Amiodarone Hcl | 79 | $3,383 |
| Flecainide Acetate | 122 | $3,120 |
| Metoprolol Succinate | 235 | $3,008 |
| SotalolSotalol Hcl | 51 | $1,550 |
| ClopidogrelClopidogrel Bisulfate | 46 | $553 |
| Atorvastatin Calcium | 43 | $327 |
| Lisinopril | 25 | $302 |
| Amlodipine Besylate | 23 | $297 |
| Carvedilol | 29 | $216 |
| Spironolactone | 18 | $212 |
| Losartan Potassium | 23 | $198 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 14 | $188 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $37 | $153,015158 claims |
| NovartisEntresto | $143 | $55,02956 claims |
| Johnson & JohnsonXarelto | $17,063 | $50,65963 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 249 clinical cardiac electrophysiology providers in Florida.
Other clinical cardiac electrophysiology in Fort Lauderdale
- David KenigsbergFort Lauderdale$1M
- Jose Baez-EscuderoFort Lauderdale$196K
- Ahmed OsmanFort Lauderdale$137K
- Esteban KloostermanFort Lauderdale$116K
- Usman SiddiquiWinter Park$1.2M
- Jose Osorio FilhoMiami$1.2M
- Raul WeissMiami Beach$887K
- Naushad ShaikKissimmee$691K
- Parikshit SharmaWeston$462K
- Saumil OzaJacksonville$462K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.